Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1

Conditions

Neoplasms 44Breast Neoplasms 42Lung Neoplasms 27Carcinoma, Non-Small-Cell Lung 21Colorectal Neoplasms 19Uterine Cervical Neoplasms 13Prostatic Neoplasms 13Ovarian Neoplasms 11Head and Neck Neoplasms 11Carcinoma, Hepatocellular 11Pancreatic Neoplasms 10Melanoma 10Brain Neoplasms 9Sarcoma 7Neoplastic Cells, Circulating 7Myelodysplastic Syndromes 7Glioma 7Esophageal Neoplasms 7Endometrial Neoplasms 7Multiple Myeloma 6Gastrointestinal Neoplasms 6Disease 6Carcinoma, Renal Cell 6Triple Negative Breast Neoplasms 5Neoplasm Metastasis 5Leukemia, Myeloid, Acute 5Colonic Neoplasms 5Uveal Melanoma 4Skin Neoplasms 4Neoplasm, Residual 4

Interventions

pembrolizumab 1durvalumab 1Radiotherapy, Intensity-Modulated 1Phlebotomy 1Metabolic Flux Analysis 1Cisplatin 1Carboplatin 1Blood Specimen Collection 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lip Neoplasms × Blood Specimen Collection × 1 year × Clear all
NCT00568490 2025-07-02

Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers

Stanford University

Recruiting
200 enrolled
Head & NeckThoracic

Head and Neck Neoplasms, Lip Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡